PA
ICPT

Parallel Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Parallel Advisors’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-6
Closed – – 2770
2020
Q3 		$0 Sell
6
-16
-73% -$735 ﹤0.01% 2718
2020
Q2 		$1K Hold
22
– – ﹤0.01% 2397
2020
Q1 		$1K Hold
22
– – ﹤0.01% 2349
2019
Q4 		$3K Hold
22
– – ﹤0.01% 2152
2019
Q3 		$1K Hold
22
– – ﹤0.01% 2349
2019
Q2 		$2K Sell
22
-100
-82% -$8.95K ﹤0.01% 2141
2019
Q1 		$14K Buy
122
+100
+455% +$10.9K ﹤0.01% 1388
2018
Q4 		$2K Hold
22
– – ﹤0.01% 1936
2018
Q3 		$3K Hold
22
– – ﹤0.01% 1952
2018
Q2 		$1K Sell
22
-17
-44% -$1.25K ﹤0.01% 2038
2018
Q1 		$2K Buy
+39
New +$2.35K ﹤0.01% 1909
2017
Q4 		– Sell
-14
Closed -$1K – 2160
2017
Q3 		$1K Buy
+14
New +$1.51K ﹤0.01% 2031

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Parallel Advisors's ICPT Position: Q4 2020 in Review

Parallel Advisors sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2020, closing a stake of 6 shares.

Parallel Advisors first reported a position in ICPT in Q3 2017 and held it in 12 quarters. The position peaked at $14K in Q1 2019. 175 funds tracked by Wall St. Rank hold ICPT as of Q4 2020.

  • Parallel Advisors reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Parallel Advisors sold 6 Intercept Pharmaceuticals, Inc. shares in Q4 2020.
  • Parallel Advisors first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2017 and held it in 12 quarters.
  • Parallel Advisors's Intercept Pharmaceuticals, Inc. position peaked at $14K in Q1 2019.
  • 175 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2020.

Based on Parallel Advisors's 13F filing for Q4 2020, filed 2 Feb 2021.